HOME › Press Releases › Microfluidics Market worth $7.5 Billion by 2020
Microfluidics Market worth $7.5 Billion by 2020
The report “Microfluidics Market by Material (Polymer, Glass, Silicon) Application (Pharmaceutical (Genomics, Proteomics, Capillary Electrophoresis) Diagnostic (POC, Clinical, Environmental, Industrial) Drug Delivery (Inhaler, Micropump)) - Global Forecast to 2020” The Global Microfluidics Market Is Valued at ~$3 Billion in 2015
Browse 123 market data tables and 32 figures spread through 200 pages and in-depth TOC on “Microfluidics Market by Material (Polymer, Glass, Silicon) Application (Pharmaceutical (Genomics, Proteomics, Capillary Electrophoresis) Diagnostic (POC, Clinical, Environmental, Industrial) Drug Delivery (Inhaler, Micropump)) - Global Forecast to 2020"
Early buyers will receive 10% customization on reports.
The Microfluidics market is expected to reach $7.5 Billion by 2020 from $3.1 Billion in 2015, at a CAGR of 19.3%. The microfluidics market witnessed healthy growth during the last decade due to the growing pharmaceutical and biotechnology research funding, rising incidences of lifestyle diseases, and rising geriatric population, globally. However, high prices of microfluidic proteomic and genomic analysis platforms, low market visibility of microfluidic products currently available in the market, and reluctance among researchers to use microfluidic technology products are inhibiting the growth of this market to a certain extent.
In this report, the microfluidics market is segmented on the basis of materials and applications. On the basis of materials, the market is categorized into polymer-based microfluidics, glass-based microfluidics, silicon-based microfluidics, and other material-based microfluidics. On the basis of applications, the microfluidics market is categorized into pharmaceutical research, in vitro diagnostics, and drug delivery. The pharmaceutical research application market is further divided into three major segments, namely, lab analytics (cell-based assays, proteomic analysis, genomic analysis, and capillary electrophoresis), dispensing, and microreaction. The in vitro diagnostics application segment is categorized into clinical diagnostics, point-of-care testing, environmental testing, industrial testing, and agro food testing. The drug delivery application segment is subdivided into inhalers, microneedles, and micropumps.
In 2014, the in vitro diagnostics segment accounted for the largest share of the market. Factors such as increasing incidences of chronic diseases, rising aging population, increasing healthcare spending from emerging countries, growing demand for point-of-care testing, emerging technologies like molecular diagnostics, and growing out-of-pocket healthcare spending are boosting the growth of the in vitro diagnostics market.
On the basis of regions, North America accounted for the largest share of this market in 2014, followed by Europe, Asia-Pacific, and RoW. However, the Asia-Pacific region is the fastest-growing market for microfluidics products, primarily due to the rising aging population and increasing R&D and healthcare expenditure in this region. In addition, large-scale improvements in the healthcare infrastructure of countries such as China, Taiwan, and India are propelling the growth of this market.
Major players in the global microfluidics market include Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), and PerkinElmer, Inc. (U.S.).
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
North - Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252